BROUGHT TO YOU BY:

ETF Portfolio Builder

New

ETF Portfolio Builder

New

PBEvsPJPETF Comparison

ETF 1

PBE

Invesco Dynamic Biotechnology & Genome ETF

This fund is part of

BioTech & Genomics

+4.79%

Full PBE fund page

VS

ETF 2

PJP

Invesco Dynamic Pharmaceuticals ETF

This fund is part of

US Health Care

+0.44%

Full PJP fund page

Invesco Dynamic Biotechnology & Genome ETF (PBE) belongs to the BioTech & Genomics segment. Invesco Dynamic Pharmaceuticals ETF (PJP) is part of the US Health Care segment. Both ETFs have the same top 1 sector exposures: Healthcare. PBE is more expensive with a Total Expense Ratio (TER) of 0.59%, versus 0.58% for PJP. PBE is up 24.01% year-to-date (YTD) with +$113M in YTD flows. PJP performs worse with 21.88% YTD performance, and +$174M in YTD flows. Run a side-by-side ETF comparison of PBE and PJP below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios. Discover our library of Model portfolios

PBE vs PJP performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Data Services

Historic performance and flows

Data as of 10/27/2026

		1M	3M	YTD	1Y	3Y	5Y
Perf.	PBE PJP	+3.48%-0.61%	+12.22%+5.03%	+24.01%+21.88%	+38.47%+34.02%	+95.94%+91.87%	+38.86%+71.23%
Flows	PBE PJP	-$947K-$6M	+$111M+$81M	+$113M+$174M	+$115M+$189M	+$62M+$131M	+$65M-$17M

Volatility and drawdown

		3M	1Y	3Y	5Y
Volatility	PBE PJP	+21.55%+17.64%	+20.01%+17.52%	+20.60%+16.43%	+22.69%+16.62%
Max drawdown	PBE PJP	-5.97%-7.99%	-11.70%-9.42%	-22.21%-16.11%	-32.63%-17.41%
Max drawdown duration	PBE PJP	46d69d	166d108d	324d275d	1468d788d

Trading data

Create an account to view trading data

Join for free

	PBE	PJP
Last sale 10/28/2026 at 1:30 PM	$101.87	$126.67
Previous close 10/27/2026	$100.74	$126.36
Consolidated volume 10/27/2026
Average volume 30 days
Average discount or premium 30 days
Average Bid/Ask spread 30 days

Replication quality

Data as of September 30, 2026

1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free

	PBE	PJP
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst

Main metrics

Last update 10/28/2026 at 1:30 PM

Live

Closed

	PBE	PJP
Last price	$101.87	$126.67
1D performance	+1.12%	+0.25%
AuM	$438.13 M	$561.22 M
E/R	0.59%	0.58%

Characteristics

	PBE	PJP
Management strategy	Passive	Passive
Provider	Invesco	Invesco
Benchmark	Dynamic Biotech & Genome Intellidex Index	Dynamic Pharmaceutical Intellidex Index
N° of holdings	30	28
Asset class	Equities	Equities
Trailing 12m distribution yield	Join	Join
Inception date	June 23, 2005	June 23, 2005
ESG	No	No

More PBE data on Trackinsight

More PJP data on Trackinsight

Exposure

Countries

PBE

USA

97.22%

Other

2.78%

PJP

USA

94.16%

Other

5.84%

Sectors

PBE

Healthcare

100%

Other

0%

PJP

Healthcare

100%

Other

-0%

Diversification

PBE

Total weight of top 15 holdings out of 15

63.67%

PJP

Total weight of top 15 holdings out of 15

66.71%

Top 15 holdings

Data as of August 31, 2026

PBE

CareDx, Inc.

5.49%

Amgen, Inc.

5.38%

Regeneron Pharmaceuticals, Inc.

5.26%

Vertex Pharmaceuticals, Inc.

5.21%

Royalty Pharma Plc

4.76%

Biogen, Inc.

4.75%

Gilead Sciences, Inc.

4.61%

United Therapeutics Corp.

3.77%

Omeros Corp.

3.73%

Repligen Corp.

3.57%

Illumina, Inc.

3.54%

Halozyme Therapeutics, Inc.

3.51%

Bio-Techne Corp.

3.41%

Protagonist Therapeutics, Inc.

3.37%

Alnylam Pharmaceuticals, Inc.

3.31%

PJP

Amgen, Inc.

5.72%

Abbott Laboratories

5.66%

Merck & Co., Inc.

5.49%

AbbVie, Inc.

5.33%

Johnson & Johnson

5.08%

Gilead Sciences, Inc.

4.89%

Eli Lilly & Co.

4.86%

Corcept Therapeutics, Inc.

4.79%

Pfizer Inc.

4.77%

Travere Therapeutics, Inc.

3.77%

Amneal Pharmaceuticals, Inc.

3.48%

Harmony Biosciences Holdings, Inc.

3.28%

Ocular Therapeutix, Inc.

3.23%

Perrigo Co. Plc

3.22%

Regeneron Pharmaceuticals, Inc.

3.15%

Frequently asked questions about PBE and PJP

How have the PBE and PJP ETFs performed in 2026?

As of October 27, 2026, PBE is up 24.01% year-to-date (YTD), while PJP has returned 21.88%. That puts PBE better performer ahead so far this year.

Which ETF is attracting more investor money: PBE or PJP?

Year-to-date, the PBE ETF saw +$113M in flows, compared to +$174M for PJP.

Which ETF is more volatile: PBE or PJP?

Over the past year, PBE had a volatility of 20.01%, while PJP experienced 17.52%.

Which ETF is bigger: PBE or PJP?

As of October 27, 2026, PBE holds $438.13 M in assets under management (AUM), while PJP manages $561.22 M.

What sectors do the PBE and PJP ETFs invest in?

PBE leans toward sectors like Healthcare. Meanwhile, PJP focuses on Healthcare.

What are the top holdings of the PBE ETF and PJP ETF?

PBE top holdings include CareDx, Inc., Amgen, Inc. and Regeneron Pharmaceuticals, Inc.. PJP holds in its top three: Amgen, Inc., Abbott Laboratories and Merck & Co., Inc..

PBEvsPJPETF Comparison

Invesco Dynamic Biotechnology & Genome ETF

Invesco Dynamic Pharmaceuticals ETF

PBE vs PJP performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Countries

Sectors

Diversification

Top 15 holdings

How have the PBE and PJP ETFs performed in 2026?

As of October 27, 2026, PBE is up 24.01% year-to-date (YTD), while PJP has returned 21.88%. That puts PBE better performer ahead so far this year.

Which ETF is attracting more investor money: PBE or PJP?

Year-to-date, the PBE ETF saw +$113M in flows, compared to +$174M for PJP.

Which ETF is more volatile: PBE or PJP?

Over the past year, PBE had a volatility of 20.01%, while PJP experienced 17.52%.

Which ETF is bigger: PBE or PJP?

As of October 27, 2026, PBE holds $438.13 M in assets under management (AUM), while PJP manages $561.22 M.

What sectors do the PBE and PJP ETFs invest in?

PBE leans toward sectors like Healthcare. Meanwhile, PJP focuses on Healthcare.

What are the top holdings of the PBE ETF and PJP ETF?

PBE top holdings include CareDx, Inc., Amgen, Inc. and Regeneron Pharmaceuticals, Inc.. PJP holds in its top three: Amgen, Inc., Abbott Laboratories and Merck & Co., Inc..

Which ETF is more diversified: PBE or PJP?

PBE holds 30 securities with 63.67% of its assets in the top 15. PJP has 28 securities and a top 15 weight of 66.71%.

ETFs’ Next Act: From Access to Selection